Viewing Study NCT00004412

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-02-05 @ 5:48 PM
Study NCT ID: NCT00004412
Status: COMPLETED
Last Update Posted: 2015-03-31
First Post: 1999-10-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
Sponsor: Susan P. Perrine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Skin Ulcers View
None Sickle Cell Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dermatologic disorders View
None genetic diseases and dysmorphic syndromes View
None hematologic disorders View
None rare disease View
None sickle cell anemia View
None skin ulcers View
None thalassemia major View